These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 2319513
21. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group. García-Rodríguez JA, García Sánchez JE, Trujillano I, Muñoz-Bellido JL. J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779 [Abstract] [Full Text] [Related]
22. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes]. Thabaut A, Meyran M. Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218 [Abstract] [Full Text] [Related]
32. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria. Bansal MB, Chuah SK, Thadepalli H. Am J Med; 1985 Nov 29; 79(5B):33-8. PubMed ID: 4073093 [Abstract] [Full Text] [Related]
33. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid). Villiger JW. N Z Med J; 1986 Nov 26; 99(814):914. PubMed ID: 3492692 [No Abstract] [Full Text] [Related]
34. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study. Fuchs PC, Jones RN, Barry AL, Allen SD, Aldridge KE, Gerlach EH, Sommers HM. Diagn Microbiol Infect Dis; 1988 Jan 26; 9(1):47-50. PubMed ID: 3370931 [Abstract] [Full Text] [Related]
36. Ticarcillin/clavulanate in the treatment of pelvic infections. Lucas MJ, Cox SM, Roark ML, Cunningham FG. J Reprod Med; 1990 Mar 26; 35(3 Suppl):343-7. PubMed ID: 2181121 [Abstract] [Full Text] [Related]
37. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations. Hill GB, Ayers OM, Everett BQ. J Antimicrob Chemother; 1991 Dec 26; 28(6):855-67. PubMed ID: 1816182 [Abstract] [Full Text] [Related]
38. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents. Betriu C, Sánchez A, Gómez M, Palau ML, Picazo JJ. J Antimicrob Chemother; 1999 Jan 26; 43(1):133-6. PubMed ID: 10381111 [Abstract] [Full Text] [Related]
39. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis. Sirinek KR, Levine BA. Surg Gynecol Obstet; 1991 Jan 26; 172 Suppl():30-5. PubMed ID: 2024224 [Abstract] [Full Text] [Related]
40. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. Aldridge KE, Gelfand M, Reller LB, Ayers LW, Pierson CL, Schoenknecht F, Tilton RC, Wilkins J, Henderberg A, Schiro DD. Diagn Microbiol Infect Dis; 1994 Apr 26; 18(4):235-41. PubMed ID: 7924220 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]